Literature DB >> 14557343

Aldosterone blockade in patients with systolic left ventricular dysfunction.

Bertram Pitt1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14557343     DOI: 10.1161/01.CIR.0000086776.15268.22

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  8 in total

1.  Mineralocorticoid-receptor blockade in hypertensive patients during angiotensin-converting enzyme inhibition: effects on left ventricular mass.

Authors:  Robert M Carey; Alexander G Logan
Journal:  Curr Hypertens Rep       Date:  2004-04       Impact factor: 5.369

Review 2.  Eplerenone : a review of its use in left ventricular systolic dysfunction and heart failure after acute myocardial infarction.

Authors:  Gillian M Keating; Greg L Plosker
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 3.  Clinical practice: heart failure in children. Part II: current maintenance therapy and new therapeutic approaches.

Authors:  Paul F Kantor; Luc L Mertens
Journal:  Eur J Pediatr       Date:  2010-02-02       Impact factor: 3.183

Review 4.  Multiple renin-angiotensin-aldosterone-blocking agents in heart failure: how much is too much?

Authors:  Bertram Pitt
Journal:  Curr Heart Fail Rep       Date:  2009-06

5.  Mineralocorticoid receptor antagonism attenuates vascular apoptosis and injury via rescuing protein kinase B activation.

Authors:  Yongzhong Wei; Adam T Whaley-Connell; Javad Habibi; Jenna Rehmer; Nathan Rehmer; Kamlesh Patel; Melvin Hayden; Vincent DeMarco; Carlos M Ferrario; Jamal A Ibdah; James R Sowers
Journal:  Hypertension       Date:  2008-12-29       Impact factor: 10.190

6.  Aldosterone Receptor Blockers in the Treatment of Heart Failure.

Authors:  Anita Deswal; David Yao
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-08

Review 7.  Aldosterone--a hormone of cardiovascular adaptation and maladaptation.

Authors:  Theodore L Goodfriend
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-02       Impact factor: 3.738

8.  Eplerenone: the evidence for its place in the treatment of heart failure after myocardial infarction.

Authors:  Carole Nadin
Journal:  Core Evid       Date:  2005-06-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.